Levey AS, James MT. Acute kidney Injury. Ann Intern Med. 2017;167:ITC66–80.

Article  PubMed  Google Scholar 

Huen SC, Cantley LG. Macrophages in Renal Injury and Repair. Annu Rev Physiol. 2017;79:449–69.

Article  CAS  PubMed  Google Scholar 

Pefanis A, Ierino FL, Murphy JM, Cowan PJ. Regulated necrosis in kidney ischemia-reperfusion injury. Kidney Int. 2019;96:291–301.

Article  PubMed  Google Scholar 

Jo SK, Sung SA, Cho WY, Go KJ, Kim HK. Macrophages contribute to the initiation of ischaemic acute renal failure in rats. Nephrol Dial Transpl. 2006;21:1231–9.

Article  CAS  Google Scholar 

Day YJ, Huang L, Ye H, Linden J, Okusa MD. Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: role of macrophages. Am J Physiol Ren Physiol. 2005;288:F722–31.

Article  CAS  Google Scholar 

Ferenbach DA, Sheldrake TA, Dhaliwal K, Kipari TM, Marson LP, Kluth DC, et al. Macrophage/monocyte depletion by clodronate, but not diphtheria toxin, improves renal ischemia/reperfusion injury in mice. Kidney Int. 2012;82:928–33.

Article  CAS  PubMed  Google Scholar 

Sokol CL, Luster AD. The chemokine system in innate immunity. Cold Spring Harb Perspect Biol 2015; 7.

Furuichi K, Wada T, Iwata Y, Kitagawa K, Kobayashi K, Hashimoto H, et al. CCR2 signaling contributes to ischemia-reperfusion injury in kidney. J Am Soc Nephrol. 2003;14:2503–15.

Article  PubMed  Google Scholar 

Deng M, Chen H, Long J, Song J, Xie L, Li X. Calycosin: a review of its pharmacological effects and Application prospects. Expert Rev Anti Infect Ther. 2021;19:911–25.

Article  CAS  PubMed  Google Scholar 

Zhang YY, Tan RZ, Zhang XQ, Yu Y, Yu C. Calycosin ameliorates Diabetes-Induced renal inflammation via the NF-kappaB pathway in Vitro and in vivo. Med Sci Monit. 2019;25:1671–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Elsherbiny NM, Said E, Atef H, Zaitone SA. Renoprotective effect of calycosin in high fat diet-fed/STZ injected rats: Effect on IL-33/ST2 signaling, oxidative stress and fibrosis suppression. Chem Biol Interact. 2020;315:108897.

Article  CAS  PubMed  Google Scholar 

Huang D, Shen P, Wang C, Gao J, Ye C, Wu F. Calycosin plays a protective role in diabetic kidney disease through the regulation of ferroptosis. Pharm Biol. 2022;60:990–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hu Q, Zhu B, Yang G, Jia J, Wang H, Tan R, et al. Calycosin pretreatment enhanced the therapeutic efficacy of mesenchymal stem cells to alleviate unilateral ureteral obstruction-induced renal fibrosis by inhibiting necroptosis. J Pharmacol Sci. 2023;151:72–83.

Article  CAS  PubMed  Google Scholar 

Zhang N, Guan C, Liu Z, Li C, Yang C, Xu L, et al. Calycosin attenuates renal ischemia/reperfusion injury by suppressing NF-kappaB mediated inflammation via PPARgamma/EGR1 pathway. Front Pharmacol. 2022;13:970616.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tan RZ, Wang C, Deng C, Zhong X, Yan Y, Luo Y, et al. Quercetin protects against cisplatin-induced acute kidney injury by inhibiting Mincle/Syk/NF-kappaB signaling maintained macrophage inflammation. Phytother Res. 2020;34:139–52.

Article  CAS  PubMed  Google Scholar 

Daina A, Michielin O, Zoete V. SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res. 2019;47:W357–64.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang H, Zhong X, Li J, Zhu M, Wang L, Ji X, et al. Cloning and expression of H. influenzae 49247 IgA protease in E. Coli. Mol Biotechnol. 2018;60:134–40.

Article  CAS  PubMed  Google Scholar 

Wiggins H, Rappoport J. An agarose spot assay for chemotactic invasion. Biotechniques. 2010;48:121–4.

Article  CAS  PubMed  Google Scholar 

Oh DJ, Dursun B, He Z, Lu L, Hoke TS, Ljubanovic D, et al. Fractalkine receptor (CX3CR1) inhibition is protective against ischemic acute renal failure in mice. Am J Physiol Ren Physiol. 2008;294:F264–71.

Article  CAS  Google Scholar 

Li JH, Tang Y, Lv J, Wang XH, Yang H, Tang PMK, et al. Macrophage migration inhibitory factor promotes renal injury induced by ischemic reperfusion. J Cell Mol Med. 2019;23:3867–77.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang L, Yang C, Wang L, Yang Z, Guo D, Fan C. Repurposing old drugs as novel inhibitors of human MIF from structural and functional analysis. Bioorg Med Chem Lett. 2022;55:128445.

Article  CAS  PubMed  Google Scholar 

Xie J, Yang L, Tian L, Li W, Yang L, Li L. Macrophage Migration inhibitor factor upregulates MCP-1 expression in an Autocrine Manner in Hepatocytes during Acute Mouse Liver Injury. Sci Rep. 2016;6:27665.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jankauskas SS, Wong DWL, Bucala R, Djudjaj S, Boor P. Evolving complexity of MIF signaling. Cell Signal. 2019;57:76–88.

Article  CAS  PubMed  Google Scholar 

Li J, Tang Y, Tang PMK, Lv J, Huang XR, Carlsson-Skwirut C, et al. Blocking Macrophage Migration Inhibitory factor protects against Cisplatin-Induced Acute kidney Injury in mice. Mol Ther. 2018;26:2523–32.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang L, Guo D, Fan C. Identification and structure-activity relationships of Dietary flavonoids as Human Macrophage Migration Inhibitory factor (MIF) inhibitors. J Agric Food Chem. 2021;69:10138–50.

Article  CAS  PubMed  Google Scholar 

De R, Sarkar S, Mazumder S, Debsharma S, Siddiqui AA, Saha SJ, et al. Macrophage migration inhibitory factor regulates mitochondrial dynamics and cell growth of human cancer cell lines through CD74-NF-kappaB signaling. J Biol Chem. 2018;293:19740–60.

Article  CAS  PubMed  PubMed Central  Google Scholar